Adenoma clinical trials at UCLA
2 in progress, 1 open to eligible people
Colorectal Cancer Screening in Cystic Fibrosis
open to eligible people ages 18-75
This multi-center study will compare multi-target DNA and quantitative FIT stool-based testing to colonoscopy in individuals with Cystic Fibrosis (CF) undergoing colon cancer screening with colonoscopy. The primary endpoint is detection of any adenomas, including advanced adenomas and colorectal cancer (CRC).
Los Angeles, California and other locations
Prevention of Colorectal Cancer Through Multiomics Blood Testing
Sorry, in progress, not accepting new patients
The PREEMPT CRC study is a prospective multi-center observational study to validate a blood-based test for the early detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.
Los Angeles, California and other locations
Our lead scientists for Adenoma research studies include Grant A. Turner, MD MHA FACP.
Last updated: